Clinical research sites report trial complexity as their top operational problem, with 41% naming it their biggest challenge ...

Regulatory gaps and organizational challenges slow AI adoption in clinical trials despite proven 90% reductions in data ...

Zhimeng Biopharma completes enrollment of CB03-154 Phase 2/3 ALS trial with 255 patients across China, targeting Q3 2027 ...

PROSpect's phase 3 RCT enrolled 424 children with PARDS and found neither prone positioning nor HFOV improves ventilator-free ...

CluePoints positions RBQM architecture as the structural foundation for clinical monitoring, consolidating evidence across ...

PharPoint Research joins Medrio's Early Adopter Program to shape clinical trial management system design before product ...

The PROSpect trial found neither prone positioning nor HFOV improved ventilator-free days in PARDS, and the trial design that ...

ASP-1929 + Pembrolizumab achieved 28.2-month median OS in recurrent/metastatic HNSCC, with 35% alive at four years in Phase ...

78% of moderate aortic stenosis patients have high-risk features that double mortality and heart failure hospitalization risk within two years, study shows.

Cecolin 9 shows six-month immunogenicity data in single-dose HPV trial against Gardasil 9, with final results expected in ...

Moleculin Biotech completes dosing in Phase 2/3 MIRACLE trial for AnnAraC in relapsed/refractory AML, with full data expected ...

PharPoint Research shaped Medrio CTMS design through early adopter program, influencing clinical trial monitoring workflows ...